Loading clinical trials...
Loading clinical trials...
A Descriptive and Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine Trials
Conditions
Interventions
Observation
Locations
21
United States
Alabama Vaccine CRS
Birmingham, Alabama, United States
Bridge HIV CRS
San Francisco, California, United States
The Hope Clinic of the Emory Vaccine Center CRS
Decatur, Georgia, United States
UIC Project WISH CRS
Chicago, Illinois, United States
Brigham and Women's Hospital Vaccine CRS (BWH VCRS)
Boston, Massachusetts, United States
Fenway Health Clinical Research Site CRS
Boston, Massachusetts, United States
Start Date
July 11, 2008
Primary Completion Date
July 11, 2015
Completion Date
July 1, 2016
Last Updated
April 18, 2022
NCT06627764
NCT04142047
NCT06694805
NCT07428330
NCT05398185
NCT07225530
Lead Sponsor
HIV Vaccine Trials Network
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions